Stella Pharma Corporation

Tokyo Stock Exchange 4888.T

Stella Pharma Corporation Price to Book Ratio (P/B) on January 14, 2025: 6.83

Stella Pharma Corporation Price to Book Ratio (P/B) is 6.83 on January 14, 2025, a 11.89% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Stella Pharma Corporation 52-week high Price to Book Ratio (P/B) is 8.57 on October 01, 2024, which is 25.57% above the current Price to Book Ratio (P/B).
  • Stella Pharma Corporation 52-week low Price to Book Ratio (P/B) is 4.91 on August 05, 2024, which is -28.03% below the current Price to Book Ratio (P/B).
  • Stella Pharma Corporation average Price to Book Ratio (P/B) for the last 52 weeks is 7.23.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Tokyo Stock Exchange: 4888.T

Stella Pharma Corporation

CEO Mr. Koki Uehara
IPO Date April 22, 2021
Location Japan
Headquarters ORIX Kouraibashi Building
Employees 44
Sector Health Care
Industries
Pharmaceuticals Biotechnology
Description

Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant melanoma and angiosarcoma. The company was incorporated in 2007 and is headquartered in Osaka, Japan.

StockViz Staff

January 15, 2025

Any question? Send us an email